Pulling SEC filings + quote and writing the call…
ACAD
ACADIA PHARMACEUTICALS INC
Next earnings Aug 4, 2026 · consensus $0.06 EPS, $303M rev
Last earnings -3.9% on 2026-05-06
$21.76
▲ +0.64%$21.62▼ -2.35%
over 1Y
L $20.06EODHDH $28.06
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+0.6%
1W+1.1%
1M+5.6%
3M+4.3%
YTD-17.8%
1Y-2.3%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 27 analysts
Buy
Revenue grew 11.9% YoY.
The read
Quality fundamentals and an attractive price line up (~302% below fair value) — the rarer case where both the business and the entry look good.
Sources: SEC EDGAR (CIK 0001070494, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 1:51:54 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.